264 related articles for article (PubMed ID: 26490350)
1. Bayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, Lymphatic Filariasis.
Singh BK; Michael E
Parasit Vectors; 2015 Oct; 8():522. PubMed ID: 26490350
[TBL] [Abstract][Full Text] [Related]
2. Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis.
Gambhir M; Bockarie M; Tisch D; Kazura J; Remais J; Spear R; Michael E
BMC Biol; 2010 Mar; 8():22. PubMed ID: 20236528
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous dynamics, robustness/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasis.
Michael E; Singh BK
BMC Med; 2016 Jan; 14():14. PubMed ID: 26822124
[TBL] [Abstract][Full Text] [Related]
4. Continental-scale, data-driven predictive assessment of eliminating the vector-borne disease, lymphatic filariasis, in sub-Saharan Africa by 2020.
Michael E; Singh BK; Mayala BK; Smith ME; Hampton S; Nabrzyski J
BMC Med; 2017 Sep; 15(1):176. PubMed ID: 28950862
[TBL] [Abstract][Full Text] [Related]
5. Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination.
Michael E; Sharma S; Smith ME; Touloupou P; Giardina F; Prada JM; Stolk WA; Hollingsworth D; de Vlas SJ
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006674. PubMed ID: 30296266
[TBL] [Abstract][Full Text] [Related]
6. Predicting lymphatic filariasis transmission and elimination dynamics using a multi-model ensemble framework.
Smith ME; Singh BK; Irvine MA; Stolk WA; Subramanian S; Hollingsworth TD; Michael E
Epidemics; 2017 Mar; 18():16-28. PubMed ID: 28279452
[TBL] [Abstract][Full Text] [Related]
7. Sequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in Papua New Guinea.
Singh BK; Bockarie MJ; Gambhir M; Siba PM; Tisch DJ; Kazura J; Michael E
PLoS One; 2013; 8(6):e67004. PubMed ID: 23826185
[TBL] [Abstract][Full Text] [Related]
8. Assessing endgame strategies for the elimination of lymphatic filariasis: A model-based evaluation of the impact of DEC-medicated salt.
Smith ME; Singh BK; Michael E
Sci Rep; 2017 Aug; 7(1):7386. PubMed ID: 28785097
[TBL] [Abstract][Full Text] [Related]
9. Simulating a Transmission Assessment Survey: An evaluation of current methods used in determining the elimination of the neglected tropical disease, Lymphatic Filariasis.
Weiss PS; Michael E; Richards FO
Int J Infect Dis; 2021 Jan; 102():422-428. PubMed ID: 33130207
[TBL] [Abstract][Full Text] [Related]
10. Complex ecological dynamics and eradicability of the vector borne macroparasitic disease, lymphatic filariasis.
Gambhir M; Michael E
PLoS One; 2008 Aug; 3(8):e2874. PubMed ID: 18716676
[TBL] [Abstract][Full Text] [Related]
11. Evaluating elimination thresholds and stopping criteria for interventions against the vector-borne macroparasitic disease, lymphatic filariasis, using mathematical modelling.
Sharma S; Smith ME; Bilal S; Michael E
Commun Biol; 2023 Feb; 6(1):225. PubMed ID: 36849730
[TBL] [Abstract][Full Text] [Related]
12. Modelling the distribution and transmission intensity of lymphatic filariasis in sub-Saharan Africa prior to scaling up interventions: integrated use of geostatistical and mathematical modelling.
Moraga P; Cano J; Baggaley RF; Gyapong JO; Njenga SM; Nikolay B; Davies E; Rebollo MP; Pullan RL; Bockarie MJ; Hollingsworth TD; Gambhir M; Brooker SJ
Parasit Vectors; 2015 Oct; 8():560. PubMed ID: 26496983
[TBL] [Abstract][Full Text] [Related]
13. Modelling lymphatic filariasis transmission and control: modelling frameworks, lessons learned and future directions.
Stolk WA; Stone C; de Vlas SJ
Adv Parasitol; 2015 Mar; 87():249-91. PubMed ID: 25765197
[TBL] [Abstract][Full Text] [Related]
14. What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration Programs.
Kastner RJ; Stone CM; Steinmann P; Tanner M; Tediosi F
PLoS Negl Trop Dis; 2015; 9(10):e0004147. PubMed ID: 26451729
[TBL] [Abstract][Full Text] [Related]
15. Transmission models and management of lymphatic filariasis elimination.
Michael E; Gambhir M
Adv Exp Med Biol; 2010; 673():157-71. PubMed ID: 20632536
[TBL] [Abstract][Full Text] [Related]
16. Modelling the epidemiology, transmission and control of lymphatic filariasis.
Das PK; Subramanian S
Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S153-64. PubMed ID: 12625928
[TBL] [Abstract][Full Text] [Related]
17. Role of vector control in the global program to eliminate lymphatic filariasis.
Bockarie MJ; Pedersen EM; White GB; Michael E
Annu Rev Entomol; 2009; 54():469-87. PubMed ID: 18798707
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration.
Simonsen PE; Derua YA; Magesa SM; Pedersen EM; Stensgaard AS; Malecela MN; Kisinza WN
Parasit Vectors; 2014 Nov; 7():507. PubMed ID: 25387483
[TBL] [Abstract][Full Text] [Related]
19. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
Nana-Djeunga HC; Tchouakui M; Njitchouang GR; Tchatchueng-Mbougua JB; Nwane P; Domche A; Bopda J; Mbickmen-Tchana S; Akame J; Tarini A; Epée E; Biholong BD; Zhang Y; Tougoue JJ; Kabore A; Njiokou F; Kamgno J
PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005633. PubMed ID: 28662054
[TBL] [Abstract][Full Text] [Related]
20. Predicting lymphatic filariasis elimination in data-limited settings: A reconstructive computational framework for combining data generation and model discovery.
Smith ME; Griswold E; Singh BK; Miri E; Eigege A; Adelamo S; Umaru J; Nwodu K; Sambo Y; Kadimbo J; Danyobi J; Richards FO; Michael E
PLoS Comput Biol; 2020 Jul; 16(7):e1007506. PubMed ID: 32692741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
